Status:
COMPLETED
Clinical Efficacy and Safety of Dexmedetomidine as an Adjuvant in Quadratus Lumborum Versus Epidural Block in Postoperative Lower Abdominal Cancer Surgeries
Lead Sponsor:
Assiut University
Conditions:
To Compare Efficacy of Dexmedetomidine in Bilateral Quadratus Lumborum vs Lumbar Epidural Blocks on Analgesia After Major Lower Abdominal Surgery
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Clinical efficacy and safety of dexmedetomidine as an adjuvant in quadratus lumborum versus epidural block in postoperative patients
Detailed Description
One of the main concerns of patients presenting for major abdominal surgery and anesthesiologists who are involved in postoperative care is postoperative analgesia\[1\]. Despite improvements in surgi...
Eligibility Criteria
Inclusion
- patient's 18-70years old
- ASA I-II and NYHA I-II.
- type of surgery: major lower abdominal cancer surgery
Exclusion
- Patients who refused to participate in the study.
- coagulation disorders.
- opioid dependence.
- sepsis or local infection at or near the vicinity of the block site.
- patients with psychiatric illnesses that would interfere with perception and assessment of pain.
- allergy to any of the studied drugs.
Key Trial Info
Start Date :
April 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2024
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06130670
Start Date
April 20 2024
End Date
December 31 2024
Last Update
December 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut University
Asyut, Egypt